Intellectual Property

Technology has revolutionized trademark research and it will never be the same

Trademark research has always been a pivot point in the creation and registration of any brand. The necessity, both legal and commercial, to ensure your new creation is different from anything already out there is absolutely vital for your brand’s uniqueness, growth and success in the long run. Moreover, this becomes especially true, when we’re […]

The results are in: Announcing this year’s Top 100 Global Innovators.

The Derwent Top 100 Global Innovators 2018-19 report has been published today.  This is the latest annual report which aims to identify the leading innovative organizations from around the globe, to celebrate their achievements and contributions to enriching the world through innovation, and to identify key trends and changes in the innovation ecosphere. Derwent has […]

Global Pharma Patent Battles : HIV integrase inhibitors “Raltegravir”

Introduction A Darts-ip user, Japanese Patent Attorney Ms. Yasuko Tanaka from S-Cube Corporation, introduces a recent remarkable Japanese patent decision in pharma sector. Background Shionogi (Appellant, Plaintiff) has filed a PCT patent application for HIV integrase inhibitors named “Anti-Virus Agent” (PCT/JP2002/208108, WO2003/016275) and obtained patents in several countries, including Japan and Europe.  The claimed invention […]

The unexpected consequences of GDPR

According to the European Commission, “the General Data Protection Regulation (GDPR) was put into place to ensure one set of data protection rules for all companies operating in the EU, wherever they are based.” The purpose of this important privacy regulation is to ensure that individuals, residing in EU member states, have more control over […]

Derwent Innovation coverage of German patents extended back to 1877

Germany is an important industrialised market with a long history of innovation and a well-established patent system that underlies its prosperity. It is the largest economy in Europe ahead of France and the UK, and the fourth largest in the world by nominal GDP. It is also the largest manufacturing economy in Europe with 29.1% […]

Teva Pharmaceutical, Teva Santé Europe vs. Merck Sharp & Dohme Corp

TGI of Paris; Teva Pharmaceutical, Teva Santé Europe v Merck Sharp & Dohme Corp, n° RG: 16/16178 (Darts-ip reference: darts-748-080-F-fr) – 25 October 2018 Last July, the European Court of Justice (ECJ) published (C 121/17[1]) its answer to the preliminary ruling filed by the High Court of Justice (England and Wales)[2], Chancery Division (Patents Court) (United […]

New gTLD winds of change continue to shift

Gaining access to information on the ever-changing new gTLD ecosystem remains paramount to domain registration strategies and to maintaining a successful domain portfolio. To date, more than 1,200 new generic Top Level Domains (gTLDs), have been delegated, including: Geographic terms (.NYC, .LONDON, .OSAKA) Generics (.FILM, .FASHION, .SPORT) Brands (called ‘dotbrands’ and applied for in a […]

ICANN63 Barcelona: Updates from the 20th AGM

The MarkMonitor team is pleased to provide updates from the recent ICANN meeting in Barcelona, Spain. This meeting marked the 20-year anniversary of ICANN’s existence and was ICANN’s 20th Annual General Meeting (AGM). The AGM format consists of seven days of sessions and includes two open community sessions, during which the ICANN board makes itself […]

Towards a digital healthcare ecosystem

This article is part of an ongoing State of Innovation series exploring global inventions and innovation trends in 12 key industries.  Articles in this series have been excerpted from the 2017 State of Innovation report, so reflect news and analysis at the time of publication.  Download the State of Innovation report on the Medical Devices industrynow, […]

Money in the pot: An analysis of patented cannabinoids innovation

Cannabis has been making a lot of headlines lately. Nearly a century after it was listed as a prohibited substance in the United States and elsewhere, recent years have seen a gradual shift towards acceptance—both as a medicine and as a recreational substance.  California led the way, as the first US state to approve medicinal […]